We're hiring across the US! Are you interested in joining a team that is bringing an innovative sleep apnea technology to patients? Respicardia® developed the remed?® System, an FDA-approved therapy for moderate to severe central sleep apnea in adult patients. The remed? System is an implantable technology that is designed to use phrenic nerve stimulation to activate the diaphragm and restore a natural breathing rate while sleeping.
Respicardia is headquartered near Minneapolis, Minnesota and we will base at least one Technical Specialist there, but we are accepting applications for our team nationally.
JOB SUMMARY: The Technical Specialist will have the following major responsibilities: • Provide technical support for therapy activation and titration • Support therapy optimization of the remed? System during overnight sleep studies • Train new customers to use the remed? System programmer and to perform all aspects of device programming • Work closely with the Territory Manager to support all aspects of the sales process • Create awareness of the remed? System by educating potential customers, especially sleep physicians, about the disease, therapy, indications, and clinical data • Work in a highly dynamic environment with an ever changing schedule • Provide remote technical support during scheduled “on-call” duties
POSITION REQUIREMENTS: • Bachelor’s degree in a technical field preferred • Registered Polysomnographic Technologist (RPSGT) certification, Registered Sleep Technologist (RST) certification, clinical sleep educator certification; or equivalent • Minimum 5 years of experience in the field of Sleep Medicine, preferably working in a sleep clinic or sleep laboratory • Minimum 2 years of experience in a sleep laboratory, preferably with extensive experience in scoring sleep studies and interpreting sleep study reports • Ability to communicate effectively, orally and in writing • Ability to travel extensively to support clinical and sales activities – approximately 80%
About Respicardia, Inc
Respicardia® is a leader in innovative technologies that address the unmet needs in respiratory and cardiovascular disease with safe and effective therapies. Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia is dedicated to improving patient outcomes, quality of life and overall cardiovascular health via novel transvenous neurostimulation therapies.
The remed?® System is a safe and effective treatment for moderate to severe central sleep apnea in adult patients. It offers improved patient satisfaction and an overall better quality of life. (Costanzo M, et al. The Lancet. 2016; 388: 974–82.)